Molecules with reduced half-lives, compositions and uses thereof
Details for Australian Patent Application No. 2007313300 (hide)
International Classifications
Event Publications
14 May 2009 PCT application entered the National Phase
PCT publication WO2008/048545 Priority application(s): WO2008/048545
11 June 2009 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Medimmune, LLC., Application No. 2007313300, under INID (71), correct the applicant name to MedImmune, LLC.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007313319-Obstructive sleep apnea treatment devices, systems and methods
2007313295-2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser